
NHS England Accelerates the Development of a Cholesterol Drug
The NHS will support the mass trial of an unapproved drug that should lower cholesterol. Delivered in the form of twice-yearly injections, the medicine should reduce medical costs and save the lives of people who don’t take statins. Approximately 40,000…